I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wygoda, A.
277
results:
english X
Search for persons
X
Format
Online (277)
Mediatypes
E-Books (2)
Articles (Online) (190)
OpenAccess-fulltext (85)
Sorted by: Relevance
Sorted by: Year
?
1
Hyperfractionated Radiotherapy Alone or in Sequential Combi..:
Wygoda, A.
;
Rutkowski, T.
;
Mrochem-Kwarciak, J.J.
...
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1154 , 2020
Link:
https://doi.org/10.1016/..
?
2
Concurrent ChemoRadiation (CCR) is better than Accelerated ..:
Księżniak-Baran, D.
;
Stankiewicz, M.
;
Wygoda, A.
...
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1128 , 2020
Link:
https://doi.org/10.1016/..
?
3
Does Accelerated Fractionation Improve Radiation Results in..:
Wygoda, A.
;
Mrochem-Kwarciak, J.J.
;
Rutkowski, T.
...
International Journal of Radiation Oncology*Biology*Physics. 106 (2020) 5 - p. 1145 , 2020
Link:
https://doi.org/10.1016/..
?
4
Prognostic Value of Erythropoietin (Epo), Soluble Erythropo..:
Mrochem-Kwarciak, J.J.
;
Rutkowski, T.
;
Wygoda, A.
...
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. E671 , 2019
Link:
https://doi.org/10.1016/..
?
5
PO-0721 Prognostic Value of Inflammatory Markers in Patient..:
Mrochem-Kwarciak, J.
;
Rutkowski, T.
;
Wygoda, A.
..
Radiotherapy and Oncology. 133 (2019) - p. S370 , 2019
Link:
https://doi.org/10.1016/..
?
6
NMR-based metabolomics in real-time monitoring of treatment..:
Boguszewicz, Ł.
;
Bieleń, A.
;
Mrochem-Kwarciak, J.
...
Metabolomics. 15 (2019) 8 - p. , 2019
Link:
https://doi.org/10.1007/..
?
7
Prognostic value of erythropoietin (EPO), soluble erythropo..:
Mrochem-Kwaciak, J.
;
Wygoda, A.
;
Deja, R.
...
Clinica Chimica Acta. 493 (2019) - p. S126 , 2019
Link:
https://doi.org/10.1016/..
?
8
Endogenic Erythropoietin Levels are Fluctuated and Conseque..:
Leś, D.
;
Mrochem-Kwarciak, J.J.
;
Wygoda, A.
..
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1349 , 2018
Link:
https://doi.org/10.1016/..
?
9
SBRT of Recurrent HNC Should be Most Effective in Patients ..:
Kentnowski, M.
;
Stąpór-Fudzińska, M.
;
Wygoda, A.
...
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1370-1371 , 2018
Link:
https://doi.org/10.1016/..
?
10
Prognostic Value of Reticulocyte, Immature Reticulocyte, an..:
Mrochem-Kwarciak, J.J.
;
Rutkowski, T.
;
Wygoda, A.
...
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1364 , 2018
Link:
https://doi.org/10.1016/..
?
11
PD-027: cfHPV DNA as a marker of treatment results in patie..:
Rutkowski, T.
;
Mazurek, A.
;
Snietura, M.
...
Radiotherapy and Oncology. 122 (2017) - p. 16-17 , 2017
Link:
https://doi.org/10.1016/..
?
12
The Prognostic Value of Osteopontin (OPN) and Hemoglobin (H..:
Mrochem-Kwarciak, J.J.
;
Rutkowski, T.
;
Wygoda, A.
...
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E374 , 2017
Link:
https://doi.org/10.1016/..
?
13
EP-1083: HPV as an etiological and prognostic factor for th..:
Brewczyński, A.
;
Rutkowski, T.
;
Mazurek, A.
...
Radiotherapy and Oncology. 123 (2017) - p. S595-S596 , 2017
Link:
https://doi.org/10.1016/..
?
14
PO-101: Osteopontin (OPN) as an instant, predictive marker ..:
Mrochem-Kwarciak, J.
;
Rutkowski, T.
;
Wygoda, A.
...
Radiotherapy and Oncology. 122 (2017) - p. 48-49 , 2017
Link:
https://doi.org/10.1016/..
?
15
PO-123: Hypothyroidism after radiotherapy of head and neck ..:
Dworzecka, U.
;
Wygoda, A.
;
Rutkowski, T.
..
Radiotherapy and Oncology. 122 (2017) - p. 59 , 2017
Link:
https://doi.org/10.1016/..
1-15